Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 177

1.

International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.

Guimarães PO, Lopes RD, Alexander JH, Thomas L, Hellkamp AS, Hijazi Z, Hylek EM, Gersh BJ, Garcia DA, Verheugt FWA, Hanna M, Flaker G, Vinereanu D, Granger CB.

J Thromb Thrombolysis. 2019 Apr 10. doi: 10.1007/s11239-019-01858-1. [Epub ahead of print]

PMID:
30972712
2.

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL; CABANA Investigators.

JAMA. 2019 Mar 15. doi: 10.1001/jama.2019.0693. [Epub ahead of print]

PMID:
30874766
3.

Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study.

Koerber SM, Loethen T, Turagam M, Payne J, Weachter R, Flaker G, Gold MR, Gautam S.

J Interv Card Electrophysiol. 2019 Mar;54(2):171-176. doi: 10.1007/s10840-018-0457-5. Epub 2018 Oct 15.

PMID:
30324225
4.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ; RAID Trial Investigators.

J Am Coll Cardiol. 2018 Aug 7;72(6):636-645. doi: 10.1016/j.jacc.2018.04.086.

5.

Ticagrelor as an Alternative for Clopidogrel-Associated Acute Arthritis.

Bedy SC, Kesterson JP, Flaker G.

Case Rep Emerg Med. 2018 Apr 8;2018:3786504. doi: 10.1155/2018/3786504. eCollection 2018.

6.

Digoxin and Mortality in Patients With Atrial Fibrillation.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L; ARISTOTLE Committees and Investigators.

J Am Coll Cardiol. 2018 Mar 13;71(10):1063-1074. doi: 10.1016/j.jacc.2017.12.060.

7.

Smartphone-based Arrhythmia Detection: Should we encourage patients to use the ECG in their pocket?

White RD, Flaker G.

J Atr Fibrillation. 2017 Apr 30;9(6):1605. doi: 10.4022/jafib.1605. eCollection 2017 Apr-May. Review.

8.

Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current views.

Ghadban R, Flaker G, Katta N, Alpert MA.

Hemodial Int. 2017 Oct;21 Suppl 2:S47-S56. doi: 10.1111/hdi.12600. Review.

PMID:
29064182
9.

T-wave oversensing during left ventricular pacing causing inappropriate defibrillation.

Payne J, Gautam S, Weachter R, Flaker G.

HeartRhythm Case Rep. 2017 Jul 31;3(10):464-466. doi: 10.1016/j.hrcr.2017.06.007. eCollection 2017 Oct. No abstract available.

10.

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.

Guimarães PO, Lopes RD, Wojdyla DM, Abdul-Rahim AH, Connolly SJ, Flaker GC, Wang J, Hanna M, Granger CB, Wallentin L, Lees KR, Alexander JH, McMurray JJV.

Cardiovasc Drugs Ther. 2017 Jun;31(3):295-301. doi: 10.1007/s10557-017-6728-z.

PMID:
28516318
11.

The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.

Hess PL, Healey JS, Granger CB, Connolly SJ, Ziegler PD, Alexander JH, Kowey PR, Ruff CT, Flaker G, Halperin JL, Hart RG, Lopes RD.

JAMA Cardiol. 2017 Mar 1;2(3):324-331. doi: 10.1001/jamacardio.2016.5167.

PMID:
28097334
12.

Management of bleeding in patients receiving non-vitamin K antagonists.

Balla S, Koerber S, Flaker G.

Postgrad Med J. 2017 Apr;93(1098):221-225. doi: 10.1136/postgradmedj-2016-134486. Epub 2016 Dec 16. Review.

PMID:
27986971
13.

Atrial Fibrillation In Athletes: Pathophysiology, Clinical Presentation, Evaluation and Management.

Turagam MK, Flaker GC, Velagapudi P, Vadali S, Alpert MA.

J Atr Fibrillation. 2015 Dec 31;8(4):1309. doi: 10.4022/jafib.1309. eCollection 2015 Dec. Review.

14.

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.

Guimarães PO, Wojdyla DM, Alexander JH, Thomas L, Alings M, Flaker GC, Al-Khatib SM, Hanna M, Horowitz JD, Wallentin L, Granger CB, Lopes RD.

Int J Cardiol. 2017 Jan 15;227:443-449. doi: 10.1016/j.ijcard.2016.11.014. Epub 2016 Nov 7.

PMID:
27852444
15.

Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study.

O'Donnell MJ, Eikelboom JW, Yusuf S, Diener HC, Hart RG, Smith EE, Gladstone DJ, Sharma M, Dias R, Flaker G, Avezum A, Zhu J, Lewis G, Connolly S.

Am Heart J. 2016 Aug;178:145-50. doi: 10.1016/j.ahj.2016.03.019. Epub 2016 Apr 17.

PMID:
27502862
16.

Management of Periprocedural Anticoagulation: A Survey of Contemporary Practice.

Flaker GC, Theriot P, Binder LG, Dobesh PP, Cuker A, Doherty JU.

J Am Coll Cardiol. 2016 Jul 12;68(2):217-26. doi: 10.1016/j.jacc.2016.04.042. Review.

17.

MY APPROACH to the practical management of anticoagulation in patients with atrial fibrillation.

Flaker G.

Trends Cardiovasc Med. 2016 Apr;26(3):292. doi: 10.1016/j.tcm.2015.05.022. Epub 2016 Jan 19. No abstract available.

PMID:
26874917
18.

Dobutamine-induced midcavitary gradients do not cause dyspnea.

King P, Flaker G, Weachter R, Chockalingam A.

HeartRhythm Case Rep. 2015 Nov 2;2(1):74-75. doi: 10.1016/j.hrcr.2015.10.010. eCollection 2016 Jan. No abstract available.

19.

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants.

Turagam MK, Velagapudi P, Flaker GC.

Clin Interv Aging. 2015 Sep 3;10:1431-44. doi: 10.2147/CIA.S80641. eCollection 2015. Review.

20.

The effect of the amiodarone-warfarin interaction on anticoagulation quality in a single, high-quality anticoagulation center.

White RD, Riggs KW, Ege EJ, Petroski GF, Koerber SM, Flaker G.

Blood Coagul Fibrinolysis. 2016 Mar;27(2):147-50. doi: 10.1097/MBC.0000000000000397.

PMID:
26258678

Supplemental Content

Loading ...
Support Center